Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Mednax Tumbled 12% Today Despite Higher Sales

TheMotleyFool

0 0

Why Mednax Tumbled 12% Today Despite Higher Sales

Despite reporting 9.2% year-over-year sales growth, a sharp decline in profitability sent shares in Mednax (NYSE: MD) lower Friday. Shares were down 11.9% at noon EDT.

Mednax is a large provider of neonatal and anesthesia services to medical facilities. In the past, it has relied heavily on acquiring physician practices to fuel growth; however, in the second quarter, acquisitions failed to offset headwinds due to rising costs and a drop-off in organic admissions.

IMAGE SOURCE: GETTY IMAGES.

Source: Fool.com